hydrochlorothiazide + Metoprolol
Composition
This formulation contain combination of Metoprolol and hydrochlorothiazide as active agents
Indications
primarily prescribed for the management of hypertension
Side effects
dizziness, fatigue, headache, nausea, diarrhea, and increased urination
Precautions
Patients should be monitored for signs of electrolyte imbalances, especially potassium and sodium levels
Contraindications
patients with certain heart conditions such as bradycardia (slow heart rate) or heart block
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai